Literature DB >> 18583847

Hepatitis C virus infection: an update.

F Z Al-Faleh1.   

Abstract

Hepatitis C virus (HCV) infection is widely prevalent world-wide particularly in high-risk individuals including patients on hemodialysis (HD). Parenteral route seems to be the main route of transmission of this infection though other routes also exist. The high prevalence of HCV infection in patients on HD who have never received blood transfusions points to the dialysis machine as one of the likely sources of transmission of infection. The reported prevalence of anti-HCV in patients on HD in Saudi Arabia is about 68%. The natural history of HCV shows a tendency to progress to chronic liver disease including chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The prevalence of anti-HCV in the general population varies from 0.5 to 3% and thus vigorous screening should be applied to all potential blood donors. A policy of public health education should be designed and implemented on the general public and health workers to reduce the non-parenteral spread of HCV. Separate HD machines should be considered for patients who are anti-HCV positive. Such preventive measures are vital because treatment of HCV with interferon has met with mixed success so far.

Entities:  

Year:  1995        PMID: 18583847

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  Follow-up study of hepatitis C virus infection in uremic patients on maintenance hemodialysis for 30 months.

Authors:  Nian-Song Wang; Lu-Tan Liao; Yan-Juan Zhu; Wei Pan; Fang Fang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus.

Authors:  Jie Cao; Qiuli Chen; Huaqun Zhang; Peipei Qi; Chao Liu; Xufang Yang; Niansong Wang; Baohua Qian; Jinhong Wang; Shaohua Jiang; Hua Yang; Shuhan Sun; Wei Pan
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

3.  Viral hepatitis, the battle continues.

Authors:  H M Al-Freihi
Journal:  J Family Community Med       Date:  1997-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.